NYU Grossman School of Medicine

1 in 3 people with epilepsy experience psychiatric symptoms. Depression, anxiety, and ADHD are common—and often undertreated. NYU Langone’s dual-trained clinicians are bridging the gap in care. Read more: bit.ly/4kTfSAL #Epilepsy #Psychiatry #Neuro

This month’s case features a 55-year-old patient with a 7 cm radiation-induced urethral defect and osteomyelitis. NYU Langone surgeons used robotic and microsurgical techniques to reconstruct the urethra and preserve the bladder. More: bit.ly/3H3PBBV #CaseOfTheMonth

A new study from NYU Langone outlines a potential AI-based method to help track aging cells. The tool assigns a “senescence score” based on nuclear features, which may aid future research in aging and disease. 🧬 Read: doi.org/10.1038/s41467…

In this TEDxNYU Langone Health talk, Dr. Christopher Petrilli [@PetrilliMD] shares his research on why human flaws and AI strengths are better together, and essential to healthcare’s future. Watch the full video here: youtube.com/watch?v=M0qIyo… #TEDxNYULangone

In her TEDxNYU Langone Health talk, Dr. Debra Albert shares her journey in nursing leadership and challenges the phrase “just a nurse.” Check out the full video here: youtube.com/watch?v=ABudNM… #TEDxNYULangone

On #WorldBrainDay, we’re revisiting #AAN2024, where NYU Langone’s Dr. Kara Melmed emphasized urgency in ICH care: “Time is brain—treat within 60 minutes to improve outcomes.” Learn more about our Department of Neurology: bit.ly/4lP6SxV

In his #TEDxNYULangone talk, Dr. Fritz François shares how growing up the son of Haitian immigrants—and witnessing health disparities firsthand—shaped his journey in medicine and purpose as a leader. Watch the full video here: youtu.be/R7dz4X2T5so?si…

New @nyulangone research finds Black patients lost less weight after sleeve gastrectomy than White and Hispanic peers. Social and economic factors—including stress, sleep disturbance & employment—may help explain why. 🔗 Read more: bit.ly/4lTrRiO

Dr. Megan A. Morris on reframing disability care — and the one question that could change lives. Watch her powerful #TEDxNYULangone talk now: youtube.com/watch?app=desk…

New research suggests a more targeted way to quiet harmful T cells in autoimmune disease, without broadly weakening the immune system. 🔬Findings published in Cell: bit.ly/44ruOBl #AutoimmuneResearch #Immunotherapy #Type1Diabetes #MS #Hepatitis

Discover how @nyugrossman’s Dr. Michael E. Pacold turned a basic question about oxygen into a potential cure for a rare pediatric disease. #BehindTheBreakthrough Watch the latest episode: bit.ly/45UNk6e Head to nature for the full study: go.nature.com/45W5W5R

NYU Langone’s three-year rheumatology fellowship, includes a research track combining clinical training with dedicated time for lab work, clinical studies, and publishing—preparing fellows for academic leadership. Head to Physician Focus to read more: bit.ly/4k6eKtd

NYU Langone welcomes Dr. Michael Dolinger as Director of Pediatric IBD. He’s leading the way with intestinal ultrasound—a fast, noninvasive tool transforming care for kids with Crohn’s and colitis. Read more: bit.ly/4k4JHOu

Can wearables predict prostate cancer side effects? Dr. Andrew Laccetti uses Fitbits, surveys & predictive modeling to improve life on hormone therapy—and building systems to support oncologists in the community. Read more: bit.ly/4ncq5dU

🎙️ Celebrating 20 years of innovation at @nyulangone’s Voice Center. From pioneering office-based procedures to launching an in-office fluoroscopy suite, the team leads in vocal, airway, and swallowing care. Read more: bit.ly/44e4sBw

Can a smartphone app detect psoriatic arthritis flare? NYU Langone researchers found Psorcast app can capture skin and joint symptoms with clinical accuracy, without an office visit. 📲 Read the study: bit.ly/4emgkpM #PsoriaticDisease #HealthTech

Researchers at @nyulangone + @PerlmutterCC found why some melanomas with NF1 mutations resist immunotherapy and how EGFR inhibitors, already used in other cancers, may help. Read more: bit.ly/40e4BDF

“Our early lecanemab data showed short-term clinical improvement—something we didn’t expect,” says NYU Langone neurology resident Phil Kuball, MD, who presented at #AAN2024. As #BrainAwarenessMonth continues, we're proud to support emerging voices in Alzheimer’s research. 🧠

Can we boost response & reduce toxicity in #melanoma treatment? At #ASCO25, Dr. Janice Mehnert shares Phase 2 trial results: ✅ 63.6% response rate ✅ Fewer severe side effects using IL-6 blocker + checkpoint inhibitors   Next stop: randomized Phase 2.

At #ASCO2025, NYU Grossman med student Lucas Mavromatis presented data linking GLP-1 receptor agonists to a 7% lower incidence of obesity-related cancers—compared to weight-neutral DPP-4 inhibitors. #GLP1 #ObesityResearch #CancerPrevention #NYULangone